Decades of clinical data suggest the therapeutic value of metabogenic nutriceutical supplements to promote energy and protein homeostasis in dystrophin-deficient muscle of DMD patients and animals models of the disease. This evidence concerns the gene DMD and Duchenne muscular dystrophy.